Is Etretinate Dangerous in Papillon-Lefèvre Syndrome?

Authors:
  • PMPatrizia Manuzzi
    Patrizia Manuzzi
  • FBFederico Bardazzi
    Federico Bardazzi
  • ACAngela Costa
    Angela Costa

Abstract
A 23-year-old girl affected by Papillon-Lefèvre syndrome developed, during Etretinate therapy (1 mg/kg/day), two liver abscesses caused by pyogenic bacteria and a subphrenic abscess. The immunological effects of retinoids may precipitate severe infections in patients with Papillon-Lefèvre syndrome, who probably have a basic, even though not always evident, defect of PMN chemotaxis.